Thrombospondin 1 Is an Autocrine Negative Regulator of Human Dendritic Cell Activation

Thrombospondin 1 (TSP) elicits potent antiinflammatory activities in vivo, as evidenced by persistent, multiorgan inflammation in TSP null mice. Herein, we report that DCs represent an abundant source of TSP at steady state and during activation. Human monocyte-derived immature dendritic cells (iDCs) spontaneously produce TSP, which is strongly enhanced by PGE2 and to a lesser extent by transforming growth factor (TGF) β, two soluble mediators secreted by macrophages after engulfment of damaged tissues. Shortly after activation via danger signals, DCs transiently produce interleukin (IL) 12 and tumor necrosis factor (TNF) α, thereby eliciting protective and inflammatory immune responses. Microbial stimuli increase TSP production, which is further enhanced by IL-10 or TGF-β. The endogenous TSP produced during early DC activation negatively regulates IL-12, TNF-α, and IL-10 release through its interactions with CD47 and CD36. After prolonged activation, DCs extinguish their cytokine synthesis and become refractory to subsequent stimulation, thereby favoring the return to steady state. Such “exhausted” DCs continue to release TSP but not IL-10. Disrupting TSP–CD47 interactions during their restimulation restores their cytokine production. We conclude that DC-derived TSP serves as a previously unappreciated negative regulator contributing to arrest of cytokine production, further supporting its fundamental role in vivo in the active resolution of inflammation and maintenance of steady state

Variation within and between Closely Related Species Uncovers High Intra-Specific Variability in Dispersal

Mounting evidence shows that contrasting selection pressures generate variability in dispersal patterns among individuals or populations of the same species, with potential impacts on both species dynamics and evolution. However, this variability is hardly considered in empirical works, where a single dispersal function is considered to adequately reflect the species-specific dispersal ability, suggesting thereby that within-species variation is negligible as regard to inter-specific differences in dispersal abilities. We propose here an original method to make the comparison of intra- and inter-specific variability in dispersal, by decomposing the diversity of that trait along a phylogeny of closely related species. We used as test group European butterflies that are classic study organisms in spatial ecology. We apply the analysis separately to eight metrics that reflect the dispersal propensity, the dispersal ability or the dispersal efficiency of populations and species. At the inter-specific level, only the dispersal ability showed the signature of a phylogenetic signal while neither the dispersal propensity nor the dispersal efficiency did. At the within-species level, the partitioning of dispersal diversity showed that dispersal was variable or highly variable among populations: intra-specific variability represented from 11% to 133% of inter-specific variability in dispersal metrics. This finding shows that dispersal variation is far from negligible in the wild. Understanding the processes behind this high within-species variation should allow us to properly account for dispersal in demographic models. Accordingly, to encompass the within species variability in life histories the use of more than one value per trait per species should be encouraged in the construction of databases aiming at being sources for modelling purposes

The ARIA-MASK-air® approach

Funding Information: The authors thank Ms Véronique Pretschner for submitting the paper. MASK‐air has been supported by Charité Universitätsmedizin Berlin, EU grants (EU Structural and Development Funds Languedoc Roussillon and Region PACA; POLLAR: EIT Health; Twinning: EIP on AHA; Twinning DHE: H2020; Catalyse: Horizon Europe) and educational grants from Mylan‐Viatris, ALK, GSK, Novartis, Stallergènes‐Greer and Uriach. None for the study. ® Publisher Copyright: © 2023 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.MASK-air®, a validated mHealth app (Medical Device regulation Class IIa) has enabled large observational implementation studies in over 58,000 people with allergic rhinitis and/or asthma. It can help to address unmet patient needs in rhinitis and asthma care. MASK-air® is a Good Practice of DG Santé on digitally-enabled, patient-centred care. It is also a candidate Good Practice of OECD (Organisation for Economic Co-operation and Development). MASK-air® data has enabled novel phenotype discovery and characterisation, as well as novel insights into the management of allergic rhinitis. MASK-air® data show that most rhinitis patients (i) are not adherent and do not follow guidelines, (ii) use as-needed treatment, (iii) do not take medication when they are well, (iv) increase their treatment based on symptoms and (v) do not use the recommended treatment. The data also show that control (symptoms, work productivity, educational performance) is not always improved by medications. A combined symptom-medication score (ARIA-EAACI-CSMS) has been validated for clinical practice and trials. The implications of the novel MASK-air® results should lead to change management in rhinitis and asthma.publishersversionpublishe

Hyperoxemia and excess oxygen use in early acute respiratory distress syndrome : Insights from the LUNG SAFE study

Publisher Copyright: © 2020 The Author(s). Copyright: Copyright 2020 Elsevier B.V., All rights reserved.Background: Concerns exist regarding the prevalence and impact of unnecessary oxygen use in patients with acute respiratory distress syndrome (ARDS). We examined this issue in patients with ARDS enrolled in the Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG SAFE) study. Methods: In this secondary analysis of the LUNG SAFE study, we wished to determine the prevalence and the outcomes associated with hyperoxemia on day 1, sustained hyperoxemia, and excessive oxygen use in patients with early ARDS. Patients who fulfilled criteria of ARDS on day 1 and day 2 of acute hypoxemic respiratory failure were categorized based on the presence of hyperoxemia (PaO2 > 100 mmHg) on day 1, sustained (i.e., present on day 1 and day 2) hyperoxemia, or excessive oxygen use (FIO2 ≥ 0.60 during hyperoxemia). Results: Of 2005 patients that met the inclusion criteria, 131 (6.5%) were hypoxemic (PaO2 < 55 mmHg), 607 (30%) had hyperoxemia on day 1, and 250 (12%) had sustained hyperoxemia. Excess FIO2 use occurred in 400 (66%) out of 607 patients with hyperoxemia. Excess FIO2 use decreased from day 1 to day 2 of ARDS, with most hyperoxemic patients on day 2 receiving relatively low FIO2. Multivariate analyses found no independent relationship between day 1 hyperoxemia, sustained hyperoxemia, or excess FIO2 use and adverse clinical outcomes. Mortality was 42% in patients with excess FIO2 use, compared to 39% in a propensity-matched sample of normoxemic (PaO2 55-100 mmHg) patients (P = 0.47). Conclusions: Hyperoxemia and excess oxygen use are both prevalent in early ARDS but are most often non-sustained. No relationship was found between hyperoxemia or excessive oxygen use and patient outcome in this cohort. Trial registration: LUNG-SAFE is registered with ClinicalTrials.gov, NCT02010073publishersversionPeer reviewe

La désensibilisation orale: Nouveaux aspects

SCOPUS: sh.jinfo:eu-repo/semantics/publishe

Les cofacteurs non médicamenteux de l'anaphylaxie alimentaire

Anaphylactic reaction to food is the most severe type of type 1 hypersensitivity reaction. While the factors affecting the expression of IgE sensitisation are little-known, certain conditions that lower the reactivity threshold and/or increase the severity of clinical reaction have been identified. According to available records, a number of such cofactors, are involved in around one third of cases of anaphylaxis. Questioning of the patient is crucial, and challenge tests may also be useful in some situations. The physiopathology is poorly understood and a number of hypotheses exist but do not provide satisfactory answers in terms of actual clinical needs. The study of these factors could prove useful for understanding the trigger mechanisms of anaphylaxis.SCOPUS: sh.jinfo:eu-repo/semantics/publishe

Agents microbiens environnementaux et Maladies allergiques: L’urbanisation et les défis de « Homo asepticus »

Les maladies allergiques ont fortement augmenté dans les pays industrialisés depuis les années qui ont suivi la 1ère guerre mondiale. Parmi les hypothèses proposées celle de l’implémentation de l’hygiène dans l’environnement urbain et ses conséquences sur l’exposition aux agents pathogènes a été bien documentée. Comparé à la vie rurale, l’environnement urbain entraine une exposition plus faible aux microbes et à leurs constituants moléculaires tels que les endotoxines et quasi nulle aux parasites intestinaux tels que les helminthes. Au contraire, l’exposition aux allergènes de l’environnement domestique est plus importante.Dans ce travail nous avons investigué certains aspects de la réponse inflammatoire induite par les endotoxines (une molécule pro-inflammatoires des bactéries Gram négatives) et immunitaire associée aux helminthes.1/ L'exposition chronique à l'endotoxine inhalée produit des effets paradoxaux :une protection contre le développement d'allergies IgE-médiées, d'une part, et une réaction inflammatoire des voies aériennes, d'autre part. Comme les régions de la déposition bronchique et alvéolaire pourraient jouer un rôle dans ce processus, nous avons évalué la réponse inflammatoire locale et systémique après exposition à de l'endotoxine par inhalation d'aérosols de particules de dimensions différentes. Les résultats montrent une relation entre la déposition au niveau pulmonaire et l’amplitude de la réponse inflammatoire systémique.2/ Les infections parasitaires ont une relation complexe avec les maladies allergiques. Ces deux pathologies se caractérisent par une réponse immunitaire de type Th2 (impliquant éosinophiles, immunoglobulines E (IgE), interleukine (IL)-4, IL-13,IL-5, …). Cependant, certaines helminthiases protègent des maladies allergiques. Dans cette seconde partie du travail, nous avons étudié la réponse immune induite par une infection chronique par ankylostomes chez l’humain et son évolution après traitement de l’infection. Nous confirmons que la réponse immune au cours de l’infection à ankylostome est caractérisée par une augmentation des cellules T régulatrices (Treg), qui contrôlent l’amplitude de la réponse immune aux helminthes mais montrons pour la première fois que ces Treg ont un phénotype naïf et fortement immuno-suppresseur. Deux semaines après traitement de l’infection on observait également une réponse inflammatoire caractérisée par une majoration de l’IL-6 mais aussi de l’IL-4, cytokine Th2 qui joue un rôle majeur dans la production d’IgE. Ces réponses conjointes (diminution des Treg et réponse inflammatoire de type Th2) pourraient constituer une base physiopathologique pouvant expliquer l’augmentation de la prévalence des sensibilisations allergiques après traitement d’une helminthiase. Nous montrons également que l’infection par helminthes s’accompagne d’une production d’IgE reconnaissant de nombreux allergènes dont les acariens de la poussière de maison, un des allergènes respiratoires les plus fréquents et fortement inducteur d’asthme. Le mécanisme expliquant la production de ces IgE spécifiques des acariens n’est pas connu. Il pourrait s’agir d’une production polyclonale, par présentation facilitée par les IgE ou par réactivité croisée avec des antigènes parasitaires. Ces IgE n’induisaient ni sensibilisation cutanée (tests allergiques cutanés positifs), ni symptomatologie clinique et n’étaient pas capables d’induire de dégranulation des mastocytes in vitro après stimulation allergénique. Par ailleurs, ces IgE spécifiques ne reconnaissaient ni les allergènes majeurs ni des déterminants carbohydrates de type N-glycan.En conclusion, notre travail de thèse met en lumière des mécanismes potentiels par lesquels l’exposition aux agents microbiens environnementaux peut moduler les réponses immunes et protègent potentiellement des maladies allergiques.Doctorat en Sciences médicales (Médecine)info:eu-repo/semantics/nonPublishe

La mise au point des allergies alimentaires

The prevalence of food allergies is more than 5 %, rising currently. The clinical presentations are polymorphic and involve the skin, respiratory, vascular and gut systems. The diagnosis is based on the consistancy between the allergic history and the results of the specific IgE investigations. When the relationship between the history and the IgE sensitization is not significant, an oral challenge test with food is indicated under supervision of a reference center. New approach, based on dosage of specific IgE to different constituent (recombinant protein) of each allergen, can predict the severity of the reaction and the cross reactivity between allergens, in some patients.SCOPUS: ar.jinfo:eu-repo/semantics/publishe

Upper airway disease diagnosis as a predictive biomarker of therapeutic response to biologics in severe asthma.

Asthma is a heterogeneous disease sharing airway instability but with different biology, risk factors, and response-to-therapy patterns. Biologics have revolutionized the one-size-fits-to-all approach to personalized medicine in severe asthma (SA), which relies on the identification of biomarkers that define distinct endotypes. Thus, blood eosinophils and, to some extent, exhaled nitric oxide (FeNO) can predict the response to approved anti-type 2 (T2) biologics (anti-IgE, anti-IL-5, and anti-IL-4R alpha), whereas age at onset and comorbidities such as anxiety/depression, obesity, reflux, and upper airway disease (UAD) also influence therapeutic responses in SA. In this article, focusing on the predictive value of biomarkers for the therapeutic response to biologics in SA, we first summarize the level of prediction achieved by T2 biomarkers (blood eosinophils, FeNO) and then review whether data support the predictive value of upper airway diagnosis on such outcomes. analysis of most studies with T2 biologics suggests that chronic rhinosinusitis with nasal polyps (CRSwNP) and, to a lower extent, allergic rhinitis may help in predicting clinical response. Considering that T2 biologics are now also approved for the treatment of severe CRSwNP, diagnosis of upper airway disease is a key step in determining eligibility for such therapy

Protein contact dermatitis and food allergy to mare milk.

Case ReportsLetterSCOPUS: le.jinfo:eu-repo/semantics/publishe